Suppr超能文献

改进HIV杀微生物剂格里菲斯菌素的大规模纯化方法。

Improving the large scale purification of the HIV microbicide, griffithsin.

作者信息

Fuqua Joshua L, Wanga Valentine, Palmer Kenneth E

机构信息

Owensboro Cancer Research Program, 1020 Breckenridge St., Suite 201, Owensboro, KY, 42303, USA.

University of Louisville School of Medicine, James Graham Brown Cancer Center, 529 S Jackson Street, Louisville, KY, 40202, USA.

出版信息

BMC Biotechnol. 2015 Feb 22;15(1):12. doi: 10.1186/s12896-015-0120-5.

Abstract

BACKGROUND

Griffithsin is a broad spectrum antiviral lectin that inhibits viral entry and maturation processes through binding clusters of oligomannose glycans on viral envelope glycoproteins. An efficient, scaleable manufacturing process for griffithsin active pharmaceutical ingredient (API) is essential for particularly cost-sensitive products such as griffithsin -based topical microbicides for HIV-1 prevention in resource poor settings. Our previously published purification method used ceramic filtration followed by two chromatography steps, resulting in a protein recovery of 30%. Our objective was to develop a scalable purification method for griffithsin expressed in Nicotiana benthamiana plants that would increase yield, reduce production costs, and simplify manufacturing techniques. Considering the future need to transfer griffithsin manufacturing technology to resource poor areas, we chose to focus modifying the purification process, paying particular attention to introducing simple, low-cost, and scalable procedures such as use of temperature, pH, ion concentration, and filtration to enhance product recovery.

RESULTS

We achieved >99% pure griffithsin API by generating the initial green juice extract in pH 4 buffer, heating the extract to 55°C, incubating overnight with a bentonite MgCl2 mixture, and final purification with Capto™ multimodal chromatography. Griffithsin extracted with this protocol maintains activity comparable to griffithsin purified by the previously published method and we are able to recover a substantially higher yield: 88 ± 5% of griffithsin from the initial extract. The method was scaled to produce gram quantities of griffithsin with high yields, low endotoxin levels, and low purification costs maintained.

CONCLUSIONS

The methodology developed to purify griffithsin introduces and develops multiple tools for purification of recombinant proteins from plants at an industrial scale. These tools allow for robust cost-effective production and purification of griffithsin. The methodology can be readily scaled to the bench top or industry and process components can be used for purification of additional proteins based on biophysical characteristics.

摘要

背景

格里菲斯素是一种广谱抗病毒凝集素,它通过与病毒包膜糖蛋白上的低聚甘露糖聚糖簇结合来抑制病毒的进入和成熟过程。对于资源匮乏地区基于格里菲斯素的HIV - 1预防局部杀菌剂等对成本特别敏感的产品而言,高效、可扩展的格里菲斯素活性药物成分(API)生产工艺至关重要。我们之前发表的纯化方法采用陶瓷过滤,随后进行两步色谱法,蛋白质回收率为30%。我们的目标是开发一种可扩展的纯化方法,用于从本氏烟草植物中表达的格里菲斯素,以提高产量、降低生产成本并简化制造技术。考虑到未来将格里菲斯素制造技术转移到资源匮乏地区的需求,我们选择专注于改进纯化工艺,特别关注引入简单、低成本且可扩展的程序,如利用温度、pH值、离子浓度和过滤来提高产品回收率。

结果

我们通过在pH 4缓冲液中制备初始绿色汁液提取物,将提取物加热至55°C,与膨润土MgCl₂混合物孵育过夜,并最终用Capto™多模式色谱法进行纯化,获得了纯度>99%的格里菲斯素API。用该方案提取的格里菲斯素保持了与先前发表方法纯化的格里菲斯素相当的活性,并且我们能够获得显著更高的产量:从初始提取物中回收88±5%的格里菲斯素。该方法扩大规模以生产克级量的格里菲斯素,保持了高产率、低内毒素水平和低纯化成本。

结论

所开发的纯化格里菲斯素的方法引入并开发了多种用于从植物中大规模纯化重组蛋白的工具。这些工具能够实现高效、经济的格里菲斯素生产和纯化。该方法可以很容易地扩大到实验室规模或工业规模,并且工艺组件可用于基于生物物理特性纯化其他蛋白质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cc/4349730/2934311e9425/12896_2015_120_Fig1_HTML.jpg

相似文献

1
Improving the large scale purification of the HIV microbicide, griffithsin.
BMC Biotechnol. 2015 Feb 22;15(1):12. doi: 10.1186/s12896-015-0120-5.
3
Rice endosperm is cost-effective for the production of recombinant griffithsin with potent activity against HIV.
Plant Biotechnol J. 2016 Jun;14(6):1427-37. doi: 10.1111/pbi.12507. Epub 2016 Jan 23.
4
Technoeconomic Modeling of Plant-Based Griffithsin Manufacturing.
Front Bioeng Biotechnol. 2018 Jul 24;6:102. doi: 10.3389/fbioe.2018.00102. eCollection 2018.
5
In Preparation for Outdoor Pharming: Griffithsin Can Be Expressed in and Retains Activity After Storage as Silage.
Front Bioeng Biotechnol. 2020 Mar 18;8:199. doi: 10.3389/fbioe.2020.00199. eCollection 2020.
6
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.
Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6099-104. doi: 10.1073/pnas.0901506106. Epub 2009 Mar 30.
7
Low-Cost, Large-Scale Production of the Anti-viral Lectin Griffithsin.
Front Bioeng Biotechnol. 2020 Aug 21;8:1020. doi: 10.3389/fbioe.2020.01020. eCollection 2020.
8
Bulk production of the antiviral lectin griffithsin.
Plant Biotechnol J. 2015 Oct;13(8):1160-8. doi: 10.1111/pbi.12433. Epub 2015 Jul 14.
10

引用本文的文献

2
Expression and antiviral application of exogenous lectin (griffithsin) in sweetpotatoes.
Front Plant Sci. 2024 Jul 16;15:1421244. doi: 10.3389/fpls.2024.1421244. eCollection 2024.
3
Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.
Proc Natl Acad Sci U S A. 2023 Mar 7;120(10):e2214561120. doi: 10.1073/pnas.2214561120. Epub 2023 Feb 28.
4
A Genetically Engineered Biofilm Material for SARS-CoV-2 Capturing and Isolation.
Adv Mater Interfaces. 2022 Sep 13:2201126. doi: 10.1002/admi.202201126.
5
The Advances of Broad-Spectrum and Hot Anti-Coronavirus Drugs.
Microorganisms. 2022 Jun 26;10(7):1294. doi: 10.3390/microorganisms10071294.
7
Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?
Vaccines (Basel). 2021 Jul 8;9(7):761. doi: 10.3390/vaccines9070761.
9
Plant Molecular Farming as a Strategy Against COVID-19 - The Italian Perspective.
Front Plant Sci. 2020 Dec 14;11:609910. doi: 10.3389/fpls.2020.609910. eCollection 2020.
10
The Emergency Response Capacity of Plant-Based Biopharmaceutical Manufacturing-What It Is and What It Could Be.
Front Plant Sci. 2020 Oct 20;11:594019. doi: 10.3389/fpls.2020.594019. eCollection 2020.

本文引用的文献

1
Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models.
Antimicrob Agents Chemother. 2014;58(1):120-7. doi: 10.1128/AAC.01407-13. Epub 2013 Oct 21.
3
Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus.
PLoS One. 2013 May 21;8(5):e64449. doi: 10.1371/journal.pone.0064449. Print 2013.
4
Griffithsin protects mice from genital herpes by preventing cell-to-cell spread.
J Virol. 2013 Jun;87(11):6257-69. doi: 10.1128/JVI.00012-13. Epub 2013 Mar 27.
5
Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo.
Arch Virol. 2013 Feb;158(2):349-58. doi: 10.1007/s00705-012-1489-2. Epub 2012 Oct 7.
6
The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.
Mol Pharm. 2012 Sep 4;9(9):2613-25. doi: 10.1021/mp300194b. Epub 2012 Aug 21.
7
Griffithsin has antiviral activity against hepatitis C virus.
Antimicrob Agents Chemother. 2011 Nov;55(11):5159-67. doi: 10.1128/AAC.00633-11. Epub 2011 Sep 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验